A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.

MLA

Ni, Jia-yan, et al. “A Nomogram to Predict Survival of Patients with Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization Combined with Microwave Ablation.” European Radiology, vol. 30, no. 4, Apr. 2020, pp. 2377–90. EBSCOhost, https://doi.org/10.1007/s00330-019-06438-8.

APA

Ni, J., Fang, Z., Sun, H., An, C., Huang, Z., Zhang, T., Jiang, X., Chen, Y., Xu, L., & Huang, J. (2020). A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation. European Radiology, 30(4), 2377–2390. https://doi.org/10.1007/s00330-019-06438-8

Chicago

Ni, Jia-yan, Zhu-ting Fang, Hong-liang Sun, Chao An, Zhi-mei Huang, Tian-qi Zhang, Xiong-ying Jiang, Yao-ting Chen, Lin-feng Xu, and Jin-hua Huang. 2020. “A Nomogram to Predict Survival of Patients with Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization Combined with Microwave Ablation.” European Radiology 30 (4): 2377–90. doi:10.1007/s00330-019-06438-8.